Skip to content

Progyny PGNY Additional Paid-In Capital

Additional Paid-In Capital at other companies

Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$931.26M-8.4%
Organon logo
OrganonOGN
$186M+43.1%
Voya Financial logo
Voya FinancialVOYA
$6.4B+1.5%
Natera, Inc. logo
Natera, Inc.NTRA
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.09B-27.1%
Enterprise value$1.98B-29.6%
P/E30.8×-23.7×
P/S1.6×-0.7×

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's additional paid-in capital?
Progyny (PGNY) reported additional paid-in capital of $717.76M in Q1 2026.
How has Progyny's additional paid-in capital changed year-over-year?
Progyny's additional paid-in capital increased by 17.4% year-over-year, from $611.56M to $717.76M.
What is the long-term trend for Progyny's additional paid-in capital?
Over 5 years (2020 to 2025), Progyny's additional paid-in capital has grown at a 24.3% compound annual growth rate (CAGR), from $236.14M to $700.79M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.